Framework and dissemination plan for clinical guidelines about herb-drug interactions
Study Protocol for Developing a Methodological Framework and a Theory-informed Dissemination Plan for Herb-drug Interactions-related Clinical Practice Guidelines: a Delphi Survey and a Semi-structured Interview Study
This project will try to develop and share a practical framework using expert Delphi surveys and interviews to help clinicians and guideline developers manage herb–drug interactions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong) |
| Trial ID | NCT07248826 on ClinicalTrials.gov |
What this trial studies
The study uses a Delphi survey to build expert consensus on the key components of a methodological framework for herb–drug interaction clinical practice guidelines. Semi-structured interviews with practitioners, researchers, and policymakers will explore barriers and facilitators to guideline uptake. Findings will be used to create a theory-informed dissemination plan aimed at promoting guideline use locally and internationally. The work is coordinated from the Chinese University of Hong Kong and allows remote participation in multiple languages.
Who should consider this trial
Good fit: Ideal participants are registered Chinese medicine practitioners, herbalists, researchers in integrated Chinese–Western medicine, physicians working in integrated settings, and healthcare administrators or policymakers involved in guideline development.
Not a fit: Patients seeking direct clinical treatment or those who do not use herbal medicines are unlikely to receive direct personal benefit from this methodological project.
Why it matters
Potential benefit: If successful, this work could reduce harmful herb–drug interactions by producing clearer, evidence-based guidelines and a plan to get them used in clinical practice.
How similar studies have performed: Delphi consensus methods and theory-informed dissemination plans have successfully shaped guidelines in other clinical areas, but applying these approaches specifically to herb–drug interactions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Registered Chinese medicine practitioners, herbalists, or researchers in the field of integrated Chinese and Western medicine; * or physicians providing care in integrated Chinese and Western medicine settings; * or healthcare administrators or policymakers from clinics/hospitals directly involved in developing or reviewing clinical practice guidelines related to integrated Chinese and Western medicine. Exclusion Criteria: * Panelists who are unable to commit to participating in all rounds of the Delphi process; * or panelists who are unable to complete the online questionnaire in either Chinese or English; * or panelists who are unable to conduct the interview in either English or Cantonese.
Where this trial is running
Hong Kong, Hong Kong
- School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong — Hong Kong, Hong Kong, Hong Kong (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.